Efficacy and Safety of DBPR108 Monotherapy in Patients with Type 2 Diabetes: a 12-Week, Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial
Current Medical Research and Opinion(2020)
Key words
DBPR108,monotherapy,type 2 diabetes mellitus,DPP-4 inhibitor
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined